A vaccine produced in Russia is the most trusted with 66% of those surveyed preferring it
Moscow, December 14, 2020 – Results of an all-Russian poll conducted in November by the Public Opinion Foundation (FOM) involving more than 3,000 respondents to learn about their attitude towards vaccination against coronavirus, found 42% of respondents willing to be vaccinated in the near future. This figure was almost double that obtained by other survey companies in September-October, when similar polls recorded readiness to be vaccinated against coronavirus in 23% of respondents1.
Almost two-thirds of the FOM survey participants (63%) demonstrated awareness of Sputnik V Gamaleya Center against coronavirus, the world's first registered vaccine against coronavirus, and of the total number of survey participants aware of the Sputnik V vaccine, more than 75% said they followed information about its clinical trials.
Four out of five respondents (80%) who have an opinion on vaccination in general, have a positive attitude towards vaccinations and see the benefits of them. More than 56% of those surveyed are confident that vaccination against coronavirus can stop the pandemic.
The results of the survey indicate willingness to participate in vaccination - and preference towards the Russian vaccine against covid- is quite widespread. Sustained demand will grow in the future as further empirical confirmation of the efficacy and safety of the vaccine is demonstrated, FOM experts say.
Key facts of the poll
Among those confident the vaccine can stop the pandemic, more than 68% of respondents expressed their readiness to be vaccinated in the near future.
The highest awareness of the Sputnik V vaccine was shown by respondents with higher education (75%).
More than 75% of those who were aware of the Sputnik V vaccine followed information on its clinical trials.
More than two thirds of survey participants (68%) drew attention to the importance of the country of origin of the coronavirus vaccine. This was a very important subject for more than half of those surveyed (53%).
A Russian-made vaccine would be preferred by two-thirds of survey participants among those who care about the country of origin of the vaccine.
Among the countries that produce vaccines that provide the greatest confidence, Russia ranks first in terms of the total number of mentions with 66% of the votes, many more than Germany (23%) and the USA (12%) (respondents were asked to name 2-3 countries).
1 - https://ria.ru/20201005/privivka-1578199577.html
Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. Currently, RDIF has experience of the successful joint implementation of more than 80 projects with foreign partners totaling more than RUB1.9 tn and covering 95% of the regions of the Russian Federation. RDIF portfolio companies employ more than 800,000 people and generate revenues which equate to more than 6% of Russia’s GDP. RDIF has established joint strategic partnerships with leading international co-investors from more than 18 countries that total more than $40 bn. Further information can be found at rdif.ru
For additional information contact:
Russian Direct Investment Fund
Tel: +7 495 644 34 14, ext. 2395
Mobile: +7 916 110 31 41
E-mail: [email protected]
Andrew Leach / Maria Shiryaevskaya
Tel: +44 (0) 20 7796 4133
Message has been successfully sent!